Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice

@article{Gardiner2006PharmacogeneticsDE,
  title={Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice},
  author={S. Gardiner and E. Begg},
  journal={Pharmacological Reviews},
  year={2006},
  volume={58},
  pages={521 - 590}
}
  • S. Gardiner, E. Begg
  • Published 2006
  • Medicine
  • Pharmacological Reviews
    • The application of pharmacogenetics holds great promise for individualized therapy. However, it has little clinical reality at present, despite many claims. The main problem is that the evidence base supporting genetic testing before therapy is weak. The pharmacology of the drugs subject to inherited variability in metabolism is often complex. Few have simple or single pathways of elimination. Some have active metabolites or enantiomers with different activities and pathways of elimination… CONTINUE READING
    View on ASPET
    pharmrev.aspetjournals.org
    373 Citations
    Highly Influencial Citations
    16
    Background Citations
    125
    Methods Citations
    4
    Results Citations
    2

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    373 Citations
    Citation Type

    Citation Type

    Toward the Safer and More Effective Use of Prescription Drugs: Pharmacogenetics
    Genetic and Epigenetic Factors Affecting Cytochrome P450 Phenotype and Their Clinical Relevance
    • 4
    • PDF
    Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects
    • 56
    • Highly Influenced
    Genetic and Epigenetic Factors Affecting Cytochrome P 450 Phenotype and Their Clinical Relevance
    • PDF
    Are Pharmacogenetics and Pharmacogenomics Important for Critically III Patients
    Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice
    • 26
    GENETICS/GENOMICS AND DRUG EFFECTS
    • F. Heller
    • Medicine, Biology
    • Acta clinica Belgica
    • 2013
    • 10
    Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis.
    • 12
    The role of pharmacogenetics in nonmalignant gastrointestinal diseases
    • M. Camilleri
    • Medicine
    • Nature Reviews Gastroenterology &Hepatology
    • 2012
    • 8
    Pharmacogenomics and Personalized Medicine in the Treatment of Human Diseases
    • 1

    References

    SHOWING 1-10 OF 1,094 REFERENCES
    Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?
    • 81
    The future prospects of pharmacogenetics in oral anticoagulation therapy.
    • 58
    Inheritance and drug response.
    • 950
    • PDF
    Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
    • I. Cascorbi
    • Medicine
    • European journal of clinical investigation
    • 2003
    • 196
    Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
    • 657
    • PDF
    Pharmacokinetics of Voriconazole and Cytochrome p450 2C19 Genetic Status
    • 155
    Metabolism and pharmacokinetics of phenelzine: lack of evidence for acetylation pathway in humans.
    • 33
    Pharmacogenetics of Warfarin Elimination and its Clinical Implications
    • 311
    Cancer pharmacogenomics: achievements in basic research
    • 8
    Clinical Consequences of Cytochrome P450 2C9 Polymorphisms
    • 451